Overactive Bladder - Results from #1040

Stimulation of the Sensory Pudendal Nerve Increases Bladder Capacity in the Rat December 4, 2017

Novel biomarkers of overactive bladder syndrome December 4, 2017

Dealing with complex overactive bladder syndrome patient profiles with focus on fesoterodine: in or out of the EAU guidelines? December 4, 2017

Impact of coexisting overactive bladder in Medicare patients with osteoporosis December 4, 2017

A systematic review and meta-analysis of effectiveness and safety of therapy for overactive bladder using botulinum toxin A at different dosages November 27, 2017

Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study November 27, 2017

Inhibition of salivary secretion by tolterodine transdermal patch November 27, 2017

Comparison of cardiovascular events among treatments for overactive bladder: a Danish nationwide cohort study November 20, 2017

Physician-patient communication about overactive bladder: Results of an observational sociolinguistic study November 20, 2017

Is overactive bladder microvasculature disease a component of systemic atheroscleorosis? November 20, 2017

Comparative efficacy and tolerability of solifenacin 5 mg/day versus other oral antimuscarinic agents in overactive bladder: A systematic literature review and network meta-analysis. November 20, 2017

Replication of Mini-Sentinel Study Assessing Mirabegron and Cardiovascular Risk in Non-Mini-Sentinel Databases November 20, 2017

The practical update for family physicians in the diagnosis and management of overactive bladder and lower urinary tract symptoms November 19, 2017

A kit ligand, stem cell factor as a possible mediator inducing overactive bladder November 14, 2017

The prevalence of lower urinary tract symptoms (LUTS) in Brazil: Results from the epidemiology of LUTS (Brazil LUTS) study November 14, 2017

Perspectives for the pharmacological treatment of overactive bladder syndrome November 14, 2017

Impact of overactive bladder symptoms on work activity: The ACTIVHA study November 13, 2017

BDNF Overexpression in Bladder Induces Neuronal Changes To Mediate Bladder Overactivity November 4, 2017

A novel leadless, miniature implantable Tibial Nerve Neuromodulation System for the management of overactive bladder complaints November 4, 2017

Effectiveness and durability of solifenacin versus percutaneous tibial nerve stimulation versus their combination for the treatment of women with overactive bladder syndrome: a randomized controlled study with a follow-up of ten months October 30, 2017

Page 53 of 122